carbamates has been researched along with Ventricular Dysfunction, Left in 2 studies
Ventricular Dysfunction, Left: A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshikawa, Y | 2 |
| Zhang, GX | 2 |
| Obata, K | 2 |
| Ohga, Y | 1 |
| Matsuyoshi, H | 1 |
| Taniguchi, S | 2 |
| Takaki, M | 2 |
| Takeshita, D | 1 |
| Tanaka, M | 1 |
| Mitsuyama, S | 1 |
| Ito, H | 1 |
2 other studies available for carbamates and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Cardioprotective effects of a novel calpain inhibitor SNJ-1945 for reperfusion injury after cardioplegic cardiac arrest.
Topics: Animals; Calcium; Calcium Channels, L-Type; Calpain; Carbamates; Cardiotonic Agents; Carrier Protein | 2010 |
A new calpain inhibitor protects left ventricular dysfunction induced by mild ischemia-reperfusion in in situ rat hearts.
Topics: Animals; Biomechanical Phenomena; Blotting, Western; Calcium; Calpain; Carbamates; Cardiotonic Agent | 2013 |